Chapter 51 Flashcards

Drugs for Heart Failure (48 cards)

1
Q

MAJOR CLASSES FOR HF
-What are the 5 types?

A
  1. ACE-I
  2. Angiotensin II receptor blockers (ARBs)
  3. Aldosterone antagonists
  4. Cardiac glycosides (Digoxin)
  5. Angiotensin receptor neprilysin inhibitors (ARNIs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ACE-I
-What are some examples? (3)

A

-Enalapril, lisinopril, captopril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ACE-I: Therapeutic Use
-What is this the first line therapy for?
-Long term use is better for what?

A

-HF
-Heart function & preventing further damage to the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ACE-I: Hemodynamic Benefits
-What are the 4 benefits?

A
  1. Arteriolar dilation
  2. Venous dilation
  3. Suppression of aldosterone release
  4. Cardiac remodeling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ACE-I: Hemodynamic Benefits
-What does arteriolar dilation do?

A

It improves blood flow in the kidneys & other tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ACE-I: Hemodynamic Benefits
-What does venous dilation do?

A

It reduces venous pressure = reduced pulmonary congestion, peripheral edema, preload, & cardiac dilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ACE-I: Hemodynamic Benefits
-what does suppression of aldosterone release cause?

A

Enhanced excretion of sodium & water WHILE retaining potassium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ACE-I: Hemodynamic Benefits
-What does cardiac remodeling help do?

A

Improve heart structure over time, reversing harmful changes in size & shape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ACE-I: Mechanism of Action
-What does this inhibit?

A

-Conversion of angiotensin I to angiotensin II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ACE-I: Mechanism of Action
-What does this reduce? (2)

A
  1. Vasoconstriction & sodium retention caused by angiotensin II
  2. Cardiac remodeling, which slows disease progression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ACE-I: Adverse Effects
-What are they? (HHAIR)

A

-Hypotension
-Hyperkalemia
-Angioedema
-Intractable cough
-Renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ACE-I: Adverse Effects
-When does this cause renal failure?

A

If the patient has bilateral renal artery stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ACE-I: Adverse Effects
-Most seriously, this can cause what?

A

A fetal injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ARBS
-What do these end in?
-What are 2 examples?

A

-sartan
-Losartan & valsartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ARBS: Therapeutic Uses
-When is this going to be used?

A

When patients CANNOT tolerate ACE-I due to cough or angioedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ARBS: Therapeutic Uses
-How are the benefits, in relation to ACE-I

A

They are similar –> reduces mortality & symptoms BUT less cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ARBS: Mechanism of Action*
-What does this block?

A

Angiotensin II receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ARBS: Effects
-What are the 3 effects?

A
  1. Vasodilation
  2. Reduced aldosterone secretion
  3. Decreased cardiac workload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ARNI
-What kinds of medications of these?

A

Newer agents that combine ARBs with neprisylin inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ARNI
-It is okay to give these with ACE-I. (T/F)
-Why?

A

-FALSE; there is a risk of angioedema

21
Q

ARNI
-What is an example of this medication?

A

Sacubitril/valsartan

22
Q

ARNI: Therapetic Use
-Who is this used for?

A

Patients with reduced ejection fraction

23
Q

ARNI: Mechanism of Action
-What does this enhance?
-What does this block?

A

-Beneficial natriuretic peptides
-angiotensin II receptors

24
Q

ARNI: Mechanism of Action
-What are the 3 effects of this? VRI

A

-Vasodilation
-Reduced fluid retention
-Improved survival

25
**ALDOSTERONE ANTAGONISTS** -What do these end in? -What are 2 examples?
-one -Spironolactone, eplerenone
26
**ALDOSTERONE ANTAGONISTS**: *Therapeutic Use* -When are these used?
For moderate to severe HF
27
**ALDOSTERONE ANTAGONISTS**: *Mechanism of Action* -What does this block? -What does this help improve?
-Aldosterone receptors in the heart & blood vessels -Survival
28
**ALDOSTERONE ANTAGONISTS**: *Effects* -What 3 effects does this have? *PRD*
1. Promotes sodium & water excretion 2. Reduces potassium loss 3. Decreases cardiac remodeling
29
**ALDOSTERONE ANTAGONISTS**: *Effects* -What things will you do due to reduced potassium loss?
1. Monitor K+ levels 2. Watch for HYPERkalemia 3. Assess renal function
30
**ALDOSTERONE ANTAGONISTS**: *Benefits* -What 3 benefits does this give the patient?
1. Reduces symptoms 2. Decreases hospitalizations 3. Prolongs their life
31
**CARDIAC GLYCOSIDE** -What is the prime example of this class?
Digoxin
32
**CARDIAC GLYCOSIDE** -Digoxin reduces mortality (T/F)
FALSE --> it only helps control symptoms & improves QOL
33
**CARDIAC GLYCOSIDE**: *Therapeutic Uses* -Describe it. -What is it used for?
-Second-line agent -Patients with HF & atrial fibrillation
34
**CARDIAC GLYCOSIDE**: *Mechanism of action* -What does this primarily do? -It (slows/quickens) HR
-Increases myocardial contractility -Slows
35
**CARDIAC GLYCOSIDE**: *Effects* -What are 3 effects of this?
1. Increased CO 2. Reduced symptoms 3. Improved exercise tolerance
36
**CARDIAC GLYCOSIDE** -Describe its therapeutic index
NARROW TI --> patients are at risk for toxicity
37
**CARDIAC GLYCOSIDE**: *Pharmacokinetics* -Describe Metabolism & Excretion
Minimal hepatic metabolism --> excreted unchanged by kidneys
38
**CARDIAC GLYCOSIDE**: *Drug Interactions* -What 6 medications does digoxin interact with
1. Diuretics 2. ACE-I 3. ARBs 4. Sympathomimetics 5. Quinidine 6. Verapamil
39
**CARDIAC GLYCOSIDE**: *Digoxin Toxicity* -What are the 4 s/s?
1. Dysrhythmias & bradycardia 2. GI effects: N/V 3. Neurological effecs 4. Visual disturbances
40
**VASODILATOR**: *BiDil* -What is this?
A fixed-dose combination of hydralazine & isosorbide dinitrate
41
**VASODILATOR**: *BiDil* -What is this approved for treating?
HF ONLY in self-identified black individuals
42
**VASODILATOR**: *BiDil* -This is the first medication that has been approved for what?
A specific population
43
**VASODILATOR**: *BiDil* -Describe what 2 things this does.
1. Venous dilation --> reduces preload 2. Arterial dilation --> reduces afterload
44
**VASODILATOR**: *BiDil* -What is the end result?
Improved CO & reduced HF symptoms
45
**NURSING ACTIONS** -What are you going to monitor? (4)
1. VS (esp. HR & BP) 2. Electrolytes 3. Fluid status 4. Kidney function
46
**NURSING ACTIONS**: *Teaching* 1. Take medications as _____ 2. Monitor _____ ____ 3. Limit ____ intake 4. Report worsening symptoms. What are they? 5. Rise (quickly/slowly)
1. prescribed 2. daily weight 3. sodium 4. dizziness, palpitations, or chest discomfort 5. slowly
47
**NURSING ACTIONS**: *Teaching* -Can this medication be discontinued abruptly? -Why?
-NO -It can worsen HF symptoms
48
**NURSING ACTIONS**: *Teaching* -What may some patients intially experience with this medication & why?
Headaches from vasodilation